AngioDynamics, Inc. ANGO Income Statement

Angiodynamics, inc. (ANGO)

Income statement / TTM

Feb'20	Nov'19	Aug'19	May'19	Feb'19	Nov'18	Aug'18	May'18	Feb'18	Nov'17	Aug'17	May'17	Feb'17	Nov'16	Aug'16	May'16	Feb'16	Nov'15	Aug'15	May'15	Feb'15	Nov'14	Aug'14	May'14	Feb'14	Nov'13	Aug'13	May'13	Feb'13	Nov'12	Aug'12	May'12	Feb'12	Nov'11	Aug'11	May'11	Feb'11	Nov'10	Aug'10
Net sales
277,007	272,751	272,733	270,634	205,139	223,466	240,187	261,655	263,027	264,778	267,101	269,788	356,148	357,980	358,235	353,890	351,168	350,331	353,196	356,534	359,897	361,450	357,872	354,425	350,297	343,718	342,154	341,916	309,804	279,800	250,892	221,917	220,320	223,401	218,674	215,750	0	0	0
Cost of sales (exclusive of intangible amortization)
115,615	113,495	114,469	114,634	76,023	87,065	101,607	117,799	123,503	126,910	126,954	125,838	180,787	182,877	182,258	179,574	173,048	178,072	179,993	180,738	181,516	175,949	174,314	174,251	174,273	171,286	170,519	173,402	154,538	136,321	118,270	96,608	93,103	93,877	90,845	90,047	0	0	0
Gross profit
161,392	159,256	158,264	156,000	129,116	136,401	138,580	143,856	139,524	137,868	140,147	143,950	175,361	175,103	175,977	174,316	178,120	172,259	173,203	175,796	178,381	185,501	183,558	180,174	176,024	172,432	171,635	168,514	155,266	143,479	132,622	125,309	127,217	129,524	127,829	125,703	0	0	0
Operating expenses:
Research and development
29,344	27,864	27,176	28,258	26,698	26,240	25,271	24,338	24,580	24,074	23,880	24,148	25,510	25,367	25,633	25,053	24,668	25,438	25,535	26,594	27,409	27,876	28,603	28,124	27,195	25,943	25,954	26,319	25,102	23,883	21,994	20,511	20,840	21,588	21,722	21,373	0	0	0
Sales and marketing
81,203	78,654	77,804	76,829	72,784	72,408	72,112	73,109	72,901	74,310	74,812	74,865	78,552	80,089	81,998	83,743	83,814	82,658	82,816	82,351	85,639	86,540	86,077	85,305	82,123	79,943	77,541	76,121	72,282	69,564	66,740	64,505	63,290	62,041	59,987	58,123	0	0	0
General and administrative
38,137	36,652	34,920	34,902	34,087	33,092	31,370	30,991	31,361	30,689	30,988	31,133	30,777	30,627	30,870	30,583	31,214	30,926	30,630	30,031	29,074	28,906	27,531	26,902	25,873	25,474	25,973	26,186	25,517	23,905	21,620	19,033	18,094	18,006	17,554	17,828	0	0	0
Amortization of intangibles
17,900	17,600	17,600	17,100	14,104	13,604	13,204	13,900	14,110	14,270	14,461	14,600	17,494	17,592	17,784	17,964	18,086	18,816	18,344	17,966	17,140	16,200	16,528	16,600	17,155	17,221	16,989	16,617	14,552	12,558	10,751	9,309	9,488	9,420	9,262	9,234	0	0	0
Change in fair value of contingent consideration
-7,525	-7,335	-7,236	-6,776	897	319	157	250	343	434	-15,599	-15,261	-15,068	-15,221	1,036	948	1,060	-8,703	-8,467	-8,096	-7,953	-2,313	-1,915	-1,908	-1,851	2,500	0	-	0	0	-	-	0	-	-	-	-	-	-
Acquisition, restructuring and other items, net
9,913	10,898	12,205	15,127	13,200	14,827	16,865	15,432	27,414	24,987	28,082	27,510	15,521	16,813	12,865	12,591	27,774	26,794	0	-	0	0	-	10,873	11,751	13,892	13,280	13,800	18,233	18,117	17,458	15,859	0	0	0	-	-	0	-
Medical device excise tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,416	0	0	0	-	-	-	-	3,829	3,638	0	0	-	0	-	-	-	0	-	-	-	-	-	-
Total operating expenses
168,945	164,247	162,359	165,396	161,739	160,490	159,019	158,026	168,876	166,940	154,754	155,125	152,786	155,702	171,599	173,298	174,248	180,774	178,744	179,245	181,828	172,014	172,169	169,687	166,244	169,107	164,629	162,226	157,196	148,224	138,563	129,217	125,494	119,796	116,630	113,740	0	0	0
Operating loss
-7,553	-4,991	-4,095	-9,396	-32,623	-24,089	-20,439	-14,170	-29,352	-29,072	-14,607	-11,175	22,575	19,401	4,378	1,018	3,872	-8,515	-5,541	-3,449	-3,447	13,487	11,389	10,487	9,780	3,325	7,006	6,288	-1,930	-4,745	-5,941	-3,908	1,723	9,728	11,199	11,963	0	0	0
Other (expenses) income:
Interest expense, net
2,082	3,358	4,647	5,099	4,528	3,826	3,256	3,062	2,906	2,793	2,843	2,839	2,934	3,116	3,304	3,385	0	0	0	-	-	-	-	3,656	4,407	4,761	5,185	5,271	4,165	2,996	1,724	508	469	486	491	499	0	0	0
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	0	0	0	21	103	393	698	937	1,090	1,001	904	805	737	0	0	0
Other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	1,489	298	877	1,335	1,645	3,487	3,042	2,838	2,707	2,355	2,073	1,951	2,096	1,923	1,864	1,665	1,503	0	0	0
Other expense, net
-5,301	-5,436	-5,518	-5,306	-3,403	-3,186	-3,546	-3,093	-2,613	-2,520	-2,603	-3,120	-2,972	-3,230	-4,103	-4,271	-2,545	-3,662	-3,592	-4,682	-3,280	-3,919	-4,544	-5,301	-7,894	-7,803	-8,002	-7,875	-6,127	-4,371	-2,738	-1,514	-1,391	-1,446	-1,351	-1,265	0	0	0
Total other expense, net
0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from continuing operations before income tax benefit
-9,837	-8,686	-9,161	-14,702	-37,492	-28,039	-24,179	-17,263	-32,032	-31,546	-17,214	-14,295	19,053	15,441	355	-3,253	-279	-12,976	-9,932	-8,131	-6,727	9,568	6,845	5,186	1,886	-4,478	-996	-1,587	-8,057	-9,116	-8,679	-5,422	332	8,282	9,848	10,698	0	0	0
Income tax benefit
-2,871	-2,820	-2,444	-3,556	-3,132	-12,307	-12,283	-11,036	-21,292	-9,674	-8,827	-7,243	44,207	42,888	41,870	40,337	824	-7,126	-5,485	-4,743	-2,393	5,234	3,841	2,839	-528	-1,385	-133	-376	-1,196	-1,479	-1,402	-239	-741	1,630	2,246	2,581	0	0	0
Net loss from continuing operations
-6,966	-5,866	-6,717	-11,146	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income from discontinued operations, net of income tax
56,119	61,524	67,251	72,486	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss)
49,153	55,658	60,534	61,340	4,569	17,792	15,901	16,335	1,320	-9,812	3,673	5,008	-25,154	-27,447	-41,515	-43,590	-1,103	-5,850	-4,447	-3,388	-4,334	4,334	3,004	2,347	2,414	-3,093	-863	-1,211	-6,861	-7,637	-7,277	-5,183	1,073	6,652	7,602	8,117	0	0	0
Loss per share continuing operations - basic (usd per share)
-0.15	-0.07	-0.03	0.07	-0.12	-0.10	-0.15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss per share continuing operations - diluted (usd per share)
-0.15	-0.07	-0.03	0.07	-0.12	-0.10	-0.15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income per share discontinued operations - basic (usd per share)
0.00	0.00	0.00	1.50	0.14	0.15	0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income per share discontinued operations - diluted (usd per share)
0.00	0.00	0.00	1.50	0.14	0.15	0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (loss) per share
Basic (in usd per share)
-0.15	-0.07	-0.03	1.57	0.02	0.06	-0.01	0.05	0.38	0.01	0.00	-0.35	0.08	0.37	0.04	-1.20	0.02	-0.01	-0.02	-0.01	-0.12	0.03	0.01	-0.04	0.13	-0.01	-0.01	-0.04	-0.03	0.06	-0.02	-0.27	-0.07	0.09	0.05	-0.03	0.15	0.13	0.08
Diluted (in usd per share)
-0.15	-0.07	-0.03	1.57	0.02	0.06	-0.01	0.06	0.37	0.01	0.00	-0.35	0.08	0.37	0.04	-1.20	0.02	-0.01	-0.02	-0.01	-0.12	0.03	0.01	-0.04	0.13	-0.01	-0.01	-0.04	-0.03	0.06	-0.02	-0.27	-0.07	0.09	0.05	-0.04	0.15	0.13	0.08
Basic weighted average shares outstanding (in shares)
37,999	37,992	37,783	37,597	37,518	37,500	37,323	37,193	37,122	37,066	36,919	36,716	36,625	36,807	36,319	36,399	36,146	36,140	35,960	-	-	-	-	35,276	35,184	35,132	34,950	34,904	34,834	34,827	34,704	26,186	25,129	25,190	25,024	24,978	24,902	24,845	24,755
Diluted weighted average shares outstanding (in shares)
37,999	37,992	37,783	37,599	37,518	37,500	37,323	36,555	37,442	37,383	36,919	35,497	37,126	37,146	36,698	36,155	36,390	36,140	35,960	-	-	-	-	35,973	35,704	35,132	34,950	34,420	34,834	35,311	34,704	25,863	25,129	25,340	25,197	25,231	25,174	25,094	25,032